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Abstract
Human papillomavirus (HPV) is the most common sexually transmitted viral infection. Infection 
with certain types of HPV pose a major public health risk as these types are associated with 
multiple human cancers, including cervical cancer, other anogenital malignancies and an 
increasing number of head and neck cancers. The HPV life cycle is closely tied to host cell 
differentiation with late viral events such as structural gene expression and viral genome 
amplification taking place in the upper layers of the stratified epithelium. The DNA damage 
response (DDR) is an elaborate signaling network of proteins that regulate the fidelity of 
replication by detecting, signaling and repairing DNA lesions. ATM and ATR are two kinases that 
are major regulators of DNA damage detection and repair. A multitude of studies indicate that 
activation of the ATM (Ataxia telangiectasia mutated) and ATR (Ataxia telangiectasia and Rad3-
related) pathways are critical for HPV to productively replicate. This review outlines how HPV 
interfaces with the ATM- and ATR-dependent DNA damage responses throughout the viral life 
cycle to create an environment supportive of viral replication and how activation of these pathways 
could impact genomic stability.
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Introduction
HPVs are small, double-stranded, non-enveloped DNA viruses that infect stratified 
epithelium at various anatomical sites, including the skin, anogenital tract and oral cavity 
(1). Of the over 100 hundred types of HPV that have been identified, about 40 of these infect 
the genital mucosa and are categorized into high-risk and low-risk based on their association 
with cancer (2, 3). Low-risk types (e.g. HPV 6, HPV11) cause benign genital warts, and 
rarely progress to malignancy. In contrast, about 15 types are considered high-risk and are 
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the causative agents of 99% of cervical cancers (4). In addition, high-risk HPV types, 
particularly HPV16, are associated with 25% of head and neck cancers (5).
Many viruses have been shown to manipulate DNA repair pathways in order to efficiently 
replicate (6). While some viruses have evolved mechanisms to avoid or eliminate DNA 
repair machinery (e.g. Adenovirus), other viruses (e.g. SV40) activate and utilize the DDR 
to replicate their genomes (7). Numerous studies support a role for the DDR in facilitating 
HPV replication, with activation of the ATM and ATR pathways being required for 
productive viral replication (8–12). Activation of the ATR pathway may also contribute to 
the establishment of HPV genomes (13), as well as to the stable maintenance of viral 
genomes in undifferentiated cells (8, 12, 14). Three licensed HPV vaccines offer great 
promise in reducing the number of deaths due to cervical cancer, however these vaccines are 
not therapeutic. Understanding how HPV activates and utilizes DNA repair pathways to 
promote viral DNA synthesis may identify potential therapeutic targets to limit viral 
replication and block disease progression.
Viral Genome Organization
The HPV genome is maintained as a circular extrachromosamal element (episome) of 
approximately 8kb in length (1). HPV DNA is associated with histones in the virion as well 
as infected cells, forming a nucleosome pattern similar to that of cellular DNA (15, 16). The 
viral genome typically contains six to eight open reading frames (ORF) that are designated 
as early (E) or late (L) (Figure 1). The ORFs are transcribed as polycistronic messages from 
one strand of the DNA that are alternatively spliced to yield individual gene products (17). 
The early proteins are non-structural and are involved in a variety of functions ranging from 
viral genome replication to cell cycle control and immune evasion (18). E1 is an ATP-
dependent helicase that also recruits host DNA replication factors to the viral origin of 
replication (19). E2 cooperates with E1 to facilitate the initiation of viral genome replication, 
and also regulates viral gene expression from the early promoter, as well as plays a role in 
viral genome partitioning (20). E6 and E7 are the oncoproteins for the high-risk HPV types 
and perform a wide variety of functions ranging from inhibiting apoptosis to cell cycle 
manipulation to immune evasion, all of which contribute to cancer development (2, 21, 22). 
E4 and E5 play a role in virion release and immune evasion, respectively, and are also 
required for productive viral replication (23–26). L1 and L2 are structural proteins that form 
the viral capsid. A regulatory region, designated the LCR (long control region) or URR 
(upstream regulatory region), is located at the end of L1 and the start of the early region and 
contains the viral origin of replication, binding sites for E1 and E2, as well as the early 
promoter and transcription factor binding sites (18).
The HPV Life Cycle
The HPV life cycle is tightly linked to the differentiation of the host cell keratinocyte 
(Figure 2) (18). Due to the small coding capacity of the virus, HPV is reliant on cellular 
factors for viral replication. The viral life cycle encompasses three phases of replication; 
establishment, maintenance and productive, all of which are influenced by the DNA damage 
response, and these three phases are described briefly below.
Anacker and Moody Page 2
Virus Res. Author manuscript; available in PMC 2018 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Establishment Phase
HPVs infect the actively dividing cells of the basal layer of the stratified epithelium to 
establish infection (27). Virions are thought to gain access to these cells through a 
microwound (28). Upon host cell entry, viral genomes enter the nucleus, where E1, E2, E6 
and E7 are expressed from the early promoter (p97 for HPV16, 31; p105 for HPV18). E2 
binds and recruits the E1 helicase to the viral origin of replication (29–31). E1 also binds 
cellular factors required for viral replication, including polymerase alpha, topoisomerase 1 
and Replication Protein A (RPA) (19). Both E1 and E2 are required for the rapid and 
transient initial amplification of viral genomes to establish a low viral copy number (50–100 
copies per cell).
Maintenance phase
Following establishment, the viral genome is maintained is at an approximately stable 
number in the proliferating basal cells of the epithelium. While E2 is required for stable 
maintenance of viral episomes, E1 has been shown to be dispensable in some cases (20, 32, 
33). Maintenance replication of HPV genomes can occur in an ordered once per S-phase 
manner, or randomly, whereby some viral genomes may replicate several times, some once 
and some not at all (34). The mode of replication utilized depends on the type of HPV, the 
cell line used, as well as the levels of E1, with high levels of E1 driving random choice 
replication (34). E2 also contributes to episomal maintenance by ensuring equal partitioning 
of HPV genomes to daughter cells upon cell division (20). E2 accomplishes this by tethering 
viral genomes to host mitotic chromosomes through chromatin adapter proteins (35). E6 and 
E7 also contribute to the stable maintenance of viral genomes by providing an environment 
conducive to viral replication (36). This is accomplished, at least in part, through E6’s 
ability to bind and degrade p53 (22, 37, 38), which inhibits cell cycle checkpoints and 
prevents host cell apoptosis. E7 deregulates cell cycle control through its ability to bind and 
promote the degradation of the tumor suppressor Rb, as well as the related pocket proteins 
p130 and p107, resulting in the constitutive activation of E2F transcription factors (21, 39, 
40). E6 and E7 both contribute to inactivation of innate immune response pathways to block 
the antiviral response and promote replication (41).
Productive phase
When an infected basal cell divides, one of the daughter cells remains in the actively 
dividing basal layer, while the other moves upward and begins the process of terminal 
differentiation. Differentiation activates the productive amplification of viral genomes to 
hundreds to thousands of copies per cell (2, 42). Differentiation also results in activation of 
the late promoter, located in the E7 ORF (43), which drives high levels of E1 and E2 to 
facilitate productive replication (44, 45), as well as E4 and E5 (45), which are also required 
for efficient viral DNA synthesis (24, 25). How E4 functions in productive replication is not 
well defined, but may contribute through affects on cell cycle progression (23). E5 helps 
maintain a proliferative environment upon differentiation (26, 46, 47). The capsid proteins 
L1 and L2 are also expressed from the late promoter, allowing for encapsidation of newly 
replicated genomes in the uppermost layers of the epithelium (18).
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Normally, epithelial cells committed to differentiation exit the cell cycle, however, HPV 
must keep differentiating cells active in the cell cycle to provide cellular factors for viral 
replication. E7’s ability to target Rb for degradation is critical to push post-mitotic cells back 
into the cell cycle, providing an environment conducive to viral replication in differentiating 
cells (48–50). As a result, cells supportive of productive replication express markers of 
differentiation, but also of cell cycle re-entry. Traditionally, E7-induced cell cycle re-entry 
has been thought to provide an S-phase environment that allows for amplification of viral 
genomes. However, recent studies indicate that productive replication occurs post-cellular 
DNA synthesis, as cells transition from S- to G2-phase (51), likely allowing HPV access to 
cellular factors without competing with cellular DNA synthesis. The mode of replication 
HPV uses to achieve rapid amplification of viral DNA upon differentiation is not clear. 
However, there is some evidence to suggest that there is a switch from the bi-directional 
(theta) replication used to stably maintain viral genomes in undifferentiated cells to a mode 
that utilizes rolling circle replication and/or recombination (52), which likely involves DNA 
repair factors, as discussed below. A seminal study from the Laimins lab demonstrated that 
highrisk HPV31 requires activation of DDR pathways for productive replication (9). Several 
studies since this initial observation offers further support that HPV productively replicates 
using DNA repair pathways, specifically through activation of the ATM and ATR DNA 
damage kinases (8, 10, 11, 53). Below, we first describe the ATM and ATR pathways then 
discuss how HPV has been shown to influence these DNA damage repair pathways 
throughout the viral life cycle.
DNA Damage Repair Pathways
Reliable maintenance of genomic integrity is an essential function of every cell. In order to 
ensure faithful replication and maintenance of chromosomes, several mechanisms exist to 
detect and repair damaged DNA. Depending on the type of damage that occurs, the cell has 
a variety of repair pathways at its disposal. As a group, these pathways are collectively 
known as the DNA damage response (DDR). The three major regulators of the DDR are the 
ATM, ATR and DNA-PK (DNA-dependent protein kinase) kinases, which belong to the PI 
3-Kinase (PIK) family of kinases (54). Double strand DNA breaks (DSBs) can be repaired 
by either high fidelity, homologous recombination (HR) that requires ATM activity, or by the 
more error prone non-homologous end joining (NHEJ) response, which is regulated by 
DNA-PK (54). Conversely, ATR is required for repair of single-strand DNA that can result 
from stalled replication forks or processing of DSBs. (55, 56). Numerous studies have 
demonstrated that HPV exploits both the ATM and ATR DDR pathways in order to 
successfully replicate its genome (8, 12, 57). In contrast, little is known regarding the 
importance of HPV’s interaction with the DNA-PK pathway for the viral life cycle. Through 
activation of the ATM and ATR pathways, HPV is able to recruit DNA repair factors 
necessary for viral genome replication, as well as provide cellular factors for viral 
replication, which appears to be especially important upon differentiation.
ATM DNA damage repair pathway
The ATM DDR pathway is typically activated in response to DNA DSBs and primarily 
repairs DNA through HR (Figure 3). In response to ionizing radiation, DSBs are recognized 
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by the MRN complex, which is composed of Mre11, Rad50, and NBS1 (54). Mre11 has 
endonuclease and exonuclease activities important for preparing broken DNA ends for HR 
repair (58, 59). Rad50 is a member of the structural maintenance of chromosomes (SMC) 
family of proteins and interacts with the broken ends of DNA in the DSB (54). NBS1 
directly binds and localizes ATM to sites of DNA damage (60, 61). ATM is activated by its 
recruitment to DSBs by NBS1, as well as acetylation by the TIP60 acetyltransferase (62–
65). Activated ATM coordinates repair of DSBs by phosphorylating numerous downstream 
targets, including proteins involved in HR repair, such as NBS1, BRCA1, and the 
endonuclease CtIP (66). Mre11, along with CtIP and BRCA1, mediate resection of the 
broken ends, resulting in ssDNA that is rapidly coated by the ssDNA binding protein 
complex RPA. RPA is then replaced by the Rad51 recombinase, which is recruited by the 
BRCA2/PALB2 complex (54, 67). Rad51 forms nucleofilaments on ssDNA that invade into 
a homologous template, most often the sister chromatid, resulting in repair through 
recombination. HR is restricted to the S and G2 phases due to the availability of the sister 
chromatid, as well as cell cycle-dependent regulation of DNA end resection, which 
generates the 3’ single-stranded DNA necessary for homology search (68). Extensive 
formation of ssDNA prevents the binding of the KU70/KU80 heterodimer, which recruits 
DNAPK for NHEJ, resulting in the inhibition of NHEJ and the commitment of DNA repair 
towards HR (68).
Other important targets of ATM include the histone variant H2AX, as well as Chk2, and p53 
(69–71). In response to DNA damage, ATM rapidly phosphorylates H2AX (referred to as 
γH2AX), which nucleates the assembly of DNA repair factors at sites of DNA damage in a 
highly ordered fashion (69). γH2AX recruits the scaffolding protein MDC1, which is also a 
substrate of ATM. pMDC1 recruits the ubiquitin ligases RNF8 and RNF168, which 
ubiquitylate H2A/H2AX, facilitating the recruitment of BRCA1, as well as 53BP1 (54, 72). 
Phosphorylation of Chk2 results in arrest in G2 phase through phosphorylation and 
inactivation of the CDC25 phosphatase and its downstream effector CDK1 (73). A 
temporary halt in the cell cycle allows time for the DNA to be repaired before continuation 
of the cell cycle. Activation of p53 also leads to cell cycle arrest, and in the case of 
unrepaired damage, cell death through apoptosis (71).
ATR DNA damage pathway
ATR is the central coordinator of the DDR relating to replication stress and replication fork 
stalling (55, 56). Replication stress occurs due to the slowing down or stalling of replication 
fork progression and/or DNA synthesis and results in large regions of RPA-coated ssDNA 
(Figure 4). ATRIP, the regulatory partner of ATR, directly binds RPA, allowing ATR/ATRIP 
to recognize ssDNA at sites of DNA damage or stalled replication forks (74). In addition, 
RPA-ssDNA recruits the Rad17/RFC complex, which loads the 9-1-1 complex (RAD9-
HUS1-RAD1) on to DNA. Rad9 interacts with the topoisomerase IIbinding protein 1 
(TopBP1), which binds and stimulates the kinase activity of ATR. Activated ATR then 
phosphorylates its downstream effector Chk1 through the mediator protein claspin (54, 55, 
75–78). ATR/Chk1 activity is critical for cells to cope with intrinsic cellular stresses. The 
ATR/Chk1 pathway protects the genome against DNA damage and replication stress by 
regulating and coordinating multiple cellular processes including fork stabilization and 
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restart, inhibition of replication origin firing, while preventing progression through the cell 
cycle while replication is completed (56). Recent studies have shown that the activity of 
ATR/Chk1 is particularly important for the survival of cancer cells, which typically exhibit 
high levels of replication stress (79–81).
HPV manipulation of the DNA damage response pathways
Utilization of the ATM pathway during the viral life cycle
The observation by the Laimins lab that high-risk HPV31 positive cells exhibit constitutive 
activation of an ATM-dependent DDR was the first indication that HPVs may manipulate 
DNA repair pathways for viral replication (9). ATM signaling is observed in undifferentiated 
and differentiated high-risk HPV31 positive cells, and is characterized by phosphorylation of 
the downstream effector Chk2, as well as NBS1 and BRCA1. Activation of the ATM-
dependent DDR has since been extended to the high-risk types HPV16 and HPV18 (82). 
Despite markers of ATM activation throughout the viral life cycle, inhibition of ATM kinase 
activity has no detectable effect on episomal maintenance, but completely blocks productive 
replication (9). Although these results suggest that ATM activity is only required for 
replication in differentiating cells, it is important to note that knocking down ATM 
expression using siRNAs results in a 70% decrease in HPV16 copy number (14). The ATM 
effector Chk2 is also required for productive replication (9). ATM-driven Chk2 activity is 
necessary for activation of caspase-7, whose activity is required for cleavage of the E1 
helicase and productive replication (9, 83). Inhibition of Chk2 activity also results in 
decreased phosphorylated Cdc25c levels in HPV31 positive cells (9), suggesting that HPV 
may utilize ATM signaling, at least in part, to provide the G2 arrested environment required 
for amplification of viral genomes. In addition, HPV utilizes ATM to activate the p38/MK2 
pathway, which is also required for productive viral replication and acts in parallel to Chk2 
and Chk1 to elicit DNA repair (53, 84).
Understanding how, as well as why HPV activates the ATM response for viral replication 
has been an area of intense interest. Interestingly, ATM activation seems to occur in an 
MRN-independent manner in HPV positive keratinocytes (10), suggesting a non-canonical 
mechanism of ATM DDR activation (85), which has also recently been suggested for 
Adenovirus infection (86). Both E1 and E7 proteins are sufficient when expressed alone to 
induce ATM activity. In undifferentiated cells, expression of E1 induces ATM activation in a 
manner likely dependent on its ability to non-specifically bind and unwind cellular DNA, 
leading to DSB formation (82, 87). When co-expressed with E2 however, E1 and E2 form 
nuclear viral replication foci that recruit numerous DNA repair factors, including 
phosphorylated ATM (pATM), pChk2, pNBS1, BRCA1 and Rad51, as well as pChk1 and 
TopBP1, two components of the ATR response (13, 82, 88). In organotypic raft cultures 
derived from either HPV18 positive or HPV18 E7-expressing keratinocytes, Banerjee et al 
demonstrated that activation of ATM, Chk2 and Chk1 occurs in differentiating cells of the 
stratified epithelium (89), indicating a role for E7 in eliciting the ATM activity required for 
productive viral replication. Similar results were observed in HPV31 organotypic raft 
cultures (9). Interestingly, HPV31 E7 binds to the phosphorylated form of ATM (9), but 
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whether this interaction influences the activation of downstream effectors, or directs ATM to 
distinct targets is currently unclear.
Recent studies have shown that the Rb binding domain of HPV31 E7 is required to maintain 
high levels of total and phosphorylated ATM, Chk2 and Chk1, the MRN complex, as well as 
the HR factors Rad51 and BRCA1 in infected cells (90). Interestingly, E7 does not increase 
levels of DNA repair factors strictly through transcription, as one would expect given that 
targeted degradation of Rb results in the constitutive activation of E2F factors. Rather, the 
Rb binding domain of E7 allows for HPV to broadly increase the half-life of DNA repair 
factors (90). Although the mechanism is currently unclear, E7 may influence protein 
stability through binding to DNA repair factors and has been shown to interact with NBS1 
(10), BRCA1 (91) and Rad50 (10), in addition to pATM (9). Alternatively, E7-dependent 
activation of ATM may lead to increased protein stability of its downstream targets. E7 has 
also been shown to regulate the activation of ATM through the immune regulator STAT-5, 
whose activity is also required for productive viral replication (92). STAT-5 may regulate 
ATM activation in HPV positive cells by increasing the activity of the TIP60 
acetyltransferase, which is required for productive replication and must acetylate ATM to 
allow for its full activation (65, 93). These studies provide a link between the innate immune 
response and DNA damage signaling in HPV positive cells. How E7 leads to STAT-5 
activation is currently unclear, but is postulated to require E7’s Rb binding domain (92).
Multiple ATM effectors localize to sites of replication in HPV positive cells, including 
pATM, γH2AX, pChk2, γH2AX, 53BP1, RPA, the MRN complex, and the HR proteins 
Rad51 and BRCA1 (10, 82, 94, 95). Gillespie at al demonstrated that γH2AX is bound to 
HPV genomes (94), which may be important in facilitating the recruitment of downstream 
DDR factors to HPV genomes (96). The finding that Rad51 and BRCA1 localize to sites of 
viral DNA synthesis suggests that HPV may utilize ATM activity to drive productive 
replication in a recombination-dependent manner. Indeed, productively replicating viral 
genomes exhibit branched structures consistent with strand invasion and unidirectional or 
rolling circle replication, which are not observed during maintenance replication (52). 
Importantly, Rad51 and BRCA1, as well as the MRN complex are required for productive 
viral replication, but not for episomal maintenance (10, 11). Disruption of the MRN complex 
through knockdown of NBS1 expression prevents the localization of Mre11 and Rad50, as 
well as Rad51 to viral genomes upon differentiation (10), suggesting that MRN-dependent 
resection may be required for Rad51 loading onto viral DNA. In support of this, inhibition 
of Mre11’s nuclease activity blocks productive viral replication (10). The binding of Rad51, 
as well as NBS1 to HPV DNA is dependent on the deacetylase Sirtuin 1 (SIRT1), which is 
upregulated in HPV positive cells and required for productive viral replication (97, 98). 
SIRT1, as well as TIP60 both influence the DSB repair pathway of choice to HR through 
modification of cellular chromatin (99, 100), and may provide a similar role in HPV positive 
cells through effects on viral chromatin (96). As mentioned previously, BRCA1 also 
influences repair pathway choice to HR by promoting end resection (68). Given the 
requirement of Rad51, BRCA1, the MRN complex, SIRT1 and TIP60 in productive 
replication, HPV may utilize ATM activity to direct the recruitment of HR factors to viral 
genomes rather than NHEJ factors, as recently been shown for SV40 (101). How HR plays a 
role in the productive replication of HPV is currently unclear. Productive replication may 
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result in DSBs and/or stalled replication forks that require HR for repair or fork restart, 
respectively. Additionally, if HPV switches to a rolling circle replication mechanism upon 
differentiation, HR may be used to resolve concatemers into individual viral genomes 
suitable for packaging. As HR is considered a relatively error-free process, HPV may 
preferentially use this method of repair to achieve high fidelity amplification of viral 
genomes. Furthermore, productive replication is thought to take place in a G2/M arrested 
environment, when HR is most active.
Utilization of the ATR pathway during the HPV life cycle
While manipulation of the ATM DDR pathway by HPV for viral replication has become 
well established, less is known about HPV’s engagement of the ATR DDR. However, recent 
studies have shown that high-risk HPVs activate the ATR/Chk1 pathway and may require its 
activity for all three phases of replication (8, 9, 13, 82). Examining the impact of the DDR 
on establishment replication has largely been achieved through transient transfection of viral 
DNA, as producing large amounts of virus for de novo infection is cumbersome. Using a 
U20S-based model system, Reinson et al. demonstrated that transient transfection of HPV18 
genomes induces the activation of ATR and the accumulation of ATR components (γH2AX, 
ATRIP, and TopBP1) at viral replication centers in an E1-dependent manner (13). These 
results suggest that initial amplification of viral genomes may result in replication stress that 
activates the ATR pathway. In addition, 2D gel analysis of transiently replicating viral 
genomes revealed structures consistent with bi-directional theta replication, as well as 
unidirectional replication, which may involve recombination and suggests that the initial 
round of viral replication may occur through two distinct mechanisms (13). Upon initial 
infection, ATR may engage recombination/repair factors at viral replication sites that are 
important for the establishment of viral genomes. Though specific DNA repair factors have 
not been identified that are necessary for establishment replication, these studies indicate 
that recombination may be important for both the initial amplification of viral genomes, as 
well as for productive replication upon differentiation.
Activation of the ATR/Chk1 pathway is also required for the stable maintenance of viral 
episomes (8, 12, 14), and recent studies have found that ATR/Chk1 activation is also 
required for productive viral replication (8, 12). Both E7 and E1 can independently activate 
the ATR/Chk1 pathway (8, 82, 87). E7 induces ATR/Chk1 activation through a STAT5-
mediated increase in TopBP1 expression (8). The mechanism by which E1 induces ATR/
Chk1 activity is currently unclear, though may occur through replication stress or DSBs at 
viral replication centers, or from non-specific binding and unwinding of cellular DNA. The 
ATR pathway is constitutively active in HPV positive cells (8, 9), suggesting that virally 
infected cells are constantly under replication stress. The expression of high-risk E6 and E7 
proteins induces replication stress through unscheduled entry into the cell cycle, promoting 
cellular DNA synthesis in the absence of a sufficient supply of nucleotides (102, 103). 
Activation of the ATR/Chk1 pathway in response to replication stress induces a re-wiring of 
E2F signaling, resulting in increased expression of genes involved in DNA repair and 
replication to prevent DNA damage and allow for survival (104). Recent studies from our 
lab have shown that HPV31 uses the ATR/Chk1 pathway to increase expression of the small 
subunit of the ribonucleotide reductase complex, RRM2, in an E7- and E2F1-dependent 
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manner (12). RRM2 is required for the de novo synthesis of dNTPs and is necessary for the 
maintenance of nucleotide pools for productive replication in differentiating HPV31 positive 
cells (12, 105). These results suggest that E7-induced cell cycle re-entry upon differentiation 
results in replication stress and ATR/Chk1/E2F1 activation that HPV hijacks to maintain 
E2F signaling, in turn providing an environment supportive of productive viral replication.
HPV, DNA Damage and Genomic Instability
Although HPV must activate DNA repair pathways for replication, HPV-immortalized cells 
and HPV-associated cancers exhibit genomic instability (2, 106), which is critical for 
carcinogenesis and suggests that DNA repair is attenuated during progression to malignancy. 
High-risk E6 and E7 proteins can independently induce DNA damage, resulting in 
numerical and chromosomal structural instability (107). Furthermore, high-risk E7 drives 
proliferation in the presence of DNA damage by inhibiting the DNA damage checkpoint 
response through proteolytic degradation of claspin (108). As shown by Bester et al, high-
risk E6 and E7 expression results in replication stress and DNA damage that results in 
genomic instability (102). In HPV-associated cancers, the viral genome is frequently found 
integrated into the host cell genome, resulting in deregulated expression of E6 and E7 that 
can further fuel genomic instability (109, 110). Integration is random, but often occurs near 
common fragile sites (111), which are particularly prone to replication stress and DNA 
damage (112). E2, along with cellular Brd4 are thought to nucleate viral replication foci near 
fragile sites, providing a convenient supply of DNA repair factors for viral DNA synthesis 
(113). As such, replication of high-risk HPV types near cellular areas prone to DNA 
breakage may in turn facilitate viral integration, which subsequently drives cancer 
development (113). Although E6 and E7 are considered the main contributors to genomic 
instability (114), expression of E1 and E2 from viral episomes can lead to replication from 
integrated HPV origins, resulting in the amplification of viral DNA sequences and structural 
alterations in the flanking cellular sequences (115). DNA structures resulting from this 
“onion skin” type of replication results in the activation of ATM and the recruitment of both 
HR and NHEJ machinery (115), the latter of which can promote mutations and 
translocations through error-prone repair (54). These results suggest that the co-existence of 
viral episomes with integrated copies of HPV can result in genomic instability that 
contributes to carcinogenesis.
Conclusions
In this review, we have described how HPV manipulates the ATM and ATR DNA repair 
pathways for viral replication (Figure 5). HPV activates ATM mainly through E7 and E1 and 
its activity seems to be primarily required upon differentiation to drive productive replication 
in a recombination-dependent manner. Indeed, several other viruses also exhibit a 
dependence on the DDR and replication-associated recombination for replication, including 
SV40 (116), HSV (117–119), KSHV (120), and EBV (121, 122). The activation of the ATR/
Chk1 pathway in response to replication stress in HPV positive cells may ensure the 
presence of cellular factors required for viral DNA synthesis through maintenance of E2F 
signaling. This may be particularly important upon differentiation and re-entry into the cell 
cycle. Numerous repair factors localize to sites of HPV replication and are likely important 
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for viral replication during the establishment, maintenance, as well as productive phases of 
the viral life cycle. Understanding how these DNA repair factors contribute to HPV 
replication is an important area of future research. The development of more selective 
inhibitors of DDR components (e.g. ATM, ATR, Chk1, Chk2) has generated intense interest 
in targeting the DNA repair pathways for cancer treatment (123, 124). Further understanding 
of how HPV induces DNA damage and activation of repair pathways for viral replication, 
and in turn how HPV negatively impacts the repair of cellular DNA, may identify DDR 
targets that can be exploited therapeutically to treat HPV-associated diseases (124).
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Highlights
The life cycle of HPV is dependent on the differentiation of stratified epithelium
HPV requires the ATM and ATR DNA damage response pathways for viral replication
HPV replication requires the recruitment of DNA repair factors to viral genomes
HPV uses ATM activity to productively replicate in a recombination-dependent manner
ATR activity provides cellular factors for viral replication upon differentiation
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Figure 1. Genomic organization of high-risk HPV16
The open reading frames (ORF) are designated by the colored blocks. The Long Control 
Region (LCR) contains sequences for transcriptional regulation, as well as the origin of 
replication. The early promoter (p97 for HPV16) is located upstream of the E6 ORF and the 
late promoter (p670 for HPV16) is located in the E7 ORF.
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Figure 2. The HPV life cycle
HPV infects basal keratinocytes of the stratified epithelium through a microwound. HPV-
infected epithelium is diagrammed on the right, while uninfected epithelium is diagrammed 
on the left. Upon infection, HPV undergoes establishment replication to 50–100 episomal 
genome copies per cell and early viral genes are expressed. Viral genomes are stably 
maintained in the basal layer of the epithelium by replicating in Sphase with cellular DNA. 
Upon cell division, one daughter cell migrates away from the basal layer and begins to 
undergo differentiation. Differentiation triggers the productive phase of the viral life cycle, 
which results in late gene expression and viral genome amplification. Ongoing expression of 
E6 and E7 deregulates cell cycle control, pushing a subset of post-mitotic differentiating 
cells back into S-phase, providing cellular DNA synthesis machinery for productive viral 
replication. Expression of L1 and L2 in the uppermost layers of the epithelium results in the 
encapsidation of viral genomes and the release of infectious virions as the epithelium is 
shed.
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Figure 3. Schematic of the ATM DNA Damage Pathway
ATM is activated in response to DSBs and repairs damaged DNA through homologous 
recombination (HR). DSBs breaks are sensed by the MRN (Mre11, Rad50, and Nbs1) 
complex, which recruits and activates ATM through direct interaction with NBS1. Activated 
ATM in turn phosphorylates numerous downstream targets (p), including H2AX (γ), in turn 
providing a docking site for the binding of MDC1. MDC1 recruits the ubiquitin ligases 
RNF8/RNF168, which ubiquitylate (u) H2A/H2AX and promotes the recruitment of other 
DNA repair factors, including 53BP1 and BRCA1. ATM signaling to Chk2, p53 and the 
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p38/MK2 kinase complex facilitates cell cycle arrest and DNA repair, or apoptosis of the 
damage is too extensive.
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Figure 4. Schematic representation of the ATR DNA damage response pathway
ATR is activated in response to single-stranded DNA generated by replication stress (stalled 
replication forks) or resected DSBs. Single-stranded DNA (ssDNA) is coated by the 
tripartite replication protein A (RPA) complex, which recruits the ATR regulator ATRIP. 
ssDNA-RPA also recruits the Rad17/RFC complex to the replication fork, which loads the 
9-1-1 complex (RAD9-HUS1-RAD1). Rad9 then interacts with TopBP1, which plays a 
critical role in activating ATR. Claspin recruitment to the complex allows ATR to 
phosphorylate Chk1 (p) and other downstream effectors, which mediate cell cycle arrest to 
allow for DNA damage repair.
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Figure 5. Model for HPV regulation of the ATM and ATR DNA repair pathways
HPV engages both the ATM and ATR DDR pathways in order to recruit host factors and 
promote viral genome replication. E7 and E1 can independently induce ATM and ATR 
activation. Activation of ATM is crucial for DNA repair through HR and may serve to direct 
HR repair machinery to viral genomes (MRN, BRCA1, Rad51), which is required for 
productive replication. ATM-mediated Chk2 activity is required for productive replication 
and may contribute through activation of a G2/M arrest. Replication stress in HPV positive 
cells likely leads to activation of the ATR response, leading to the phosphorylation of Chk1, 
which results in elevated E2F1 protein levels. In turn, E2F1 upregulates RRM2 expression, 
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allowing for the increased production of dNTPs required for productive viral replication. See 
text for additional detail.
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